Statements of Operations (Mymd Pharmaceuticals Inc.) (Parenthetical) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Share based compensation | ||
| Mymd Pharmaceuticals Inc. [Member] | ||
| Share based compensation | $ 855,000 | $ 3,577,550 |
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|